Skip to main content
Guest homeNews home
Story
6 of 15

Metastatic bladder cancer immunotherapy outcomes better with antihistamines

Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini that found using antihistamines in patients receiving second-line immunotherapy for a certain bladder cancer may improve outcomes.

We're sorry, but this page is temporarily unavailable. To report an issue, please submit a support ticket:

Latest UC News